Pentaray Nav
Device Cardiology
PDI 10846835012262
General payments
$8,729
Research payments
$113,849
Through program year 2025, $8,729 in general payments and $113,849 in research payments were reported against Pentaray Nav (Cardiology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $55 | 4 |
| 2025 | Research | $5,000 | 1 |
| 2024 | General | $258 | 8 |
| 2024 | Research | $13,500 | 1 |
| 2023 | General | $2,800 | 45 |
| 2023 | Research | $7,970 | 2 |
| 2022 | General | $5,616 | 125 |
| 2022 | Research | $87,379 | 3 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
182 general · 7 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.